bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on an education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes on primary and secondary measures will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.
Conditions:
🦠 Aging 🦠 Mild Cognitive Impairment 🦠 Hypertension
🗓️ Study Start (Actual) 29 February 2024
🗓️ Primary Completion (Estimated) May 2025
✅ Study Completion (Estimated) December 2025
👥 Enrollment (Estimated) 100
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Tucson, Arizona, United States
📍 Champaign, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Age 60+
    • 2. Community-dwelling older adults
    • 3. Self-reported fluent in English
    • 4. Adequate self-reported visual and hearing ability
    • 5. Self-reported memory, thinking, or concentration challenges
    • 6. Self-manage at least one prescribed antihypertensive medication
    • 7. Have and use a smartphone
    • 8. No self-reported history of major depression or other mental health diagnoses
    • 9. No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease
    • 10. TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26
    • 11. Willing to participate in the study for at least 4 months

    Exclusion Criteria:

    • 1. Diagnosis of dementia
    • 2. Lives in assisted living facility or skilled nursing facility
Ages Eligible for Study: 60 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 12 February 2024
  • First Submitted that Met QC Criteria 11 March 2024
  • First Posted 13 March 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 28 March 2024
  • Last Update Posted 1 April 2024
  • Last Verified March 2024